This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum
See You Next Year! 26-28 Feb, 2025
Westin Miyako KyotoKyoto, Japan
Menu

Michael Byrne, Ph.D.
Vice President, In Vivo and CNS Biology at Wave Life Sciences
Speaker

Agenda Sessions

  • Improving Oligonucleotide Pharmacology Across Tissues and Modalities through Base, Sugar, and Backbone Modifications

    , 9:05am
    View Session

  • Chimeric PN-containing Oligonucleotides Yield Exon Skipping in Preclinical Models and Boys with Duchenne Muscular Dystrophy

    , 3:35pm
    View Session

At this event

Prev
Next
Brian Cafferty, PhD
Director
Beam Therapeutics

See Michael at TIDES Asia: Oligonucleotide & Peptide Therapeutics Scientific Forum